The biological seed treatment market is projected to reach USD 1.7 billion by 2025, from USD 0.9 billion in 2020, at a CAGR of 11.9%. The global biological seed treatment market is driven by factors such as providing an insurance to better crop yields, along with a reduction in the risk of exceeding the Maximum Residue Levels (MRLs). Low level of awareness about the benefits of biological seed treatment among farmers across the globe is a major restraint in this market.

“Corn segment is projected to account for the largest market share in the biological seed treatment market during the forecast period.”
The demand for biological seed treatment in corn has been witnessing substantial growth in the European and American regions, due to the significant requirement of corn as animal protein and ethanol in the feed and automobile industries, respectively. Thus, the corn segment accounted for the major share in the biological seed treatment market.

“Microbials segment is projected to be the fastest-growing segment, by type, in the biological seed treatment market
Microbial seed treatment includes bacterial and fungal seed treatment. Seeds treatment provides an efficient mechanism for the placement of microbial inoculum in the soil environment, where they are appropriately positioned to colonize the seedling & roots and protect them against soil-borne diseases and pests. Thus, the microbials segment is projected to grow at the highest rate during the forecast period.

The North America market is estimated to account for the largest market share due to the supportive government regulations in the region.
North America was the largest biological seed treatment market in 2020. The streamlined guidelines, procedures, and effective feedback adopted by North American agrochemical regulatory agencies have been supportive of the product registration process as compared to Europe. North America was followed by the European market in 2020 which has also witnessed a strong adoption trend of these products.

The breakdown of the primaries on the basis of company, designation, and region conducted during the research study, is as follows:

  • By Company type: Tier 1 – 60%, Tier 2 –30%, and Tier 3 – 10%
  • By Designation: CXOs – 40%, Managers – 30%, Executives* – 30%
  • By Region: North America – 20%, Europe – 30%, Asia Pacific – 35%, RoW -15%

*Others include sales managers, marketing managers, and product managers.
Note: Tier 1: Revenue >= USD 1 billion; Tier 2: USD 100 million to USD 1 billion; Tier 3: Revenue =< USD 100 million

Research Coverage
This report segments the biological seed treatment market on the basis of type, crop, function and region. In terms of insights, this research report focuses on various levels of analyses?competitive landscape, end-use analysis, and company profiles?which together comprise and discuss the basic views on the emerging & high-growth segments of the seed treatment market, the high-growth regions, countries, government initiatives, market disruption, drivers, restraints, opportunities, and challenges.

Reasons To Buy this report

  • To get a comprehensive overview of the biological seed treatmentmarket
  • To gain wide-ranging information about the top players in this industry, their product portfolios, and key strategies adopted by them
  • To gain insights about the major countries/regions, in which the biological seed treatmentmarket is flourishing